Ajay Sheshadri
1
* , MSc, MD ;
Sukh Makhnoon
2
* , MSc, PhD ;
Amin M Alousi
3
, MD ;
Lara Bashoura
1
, MD ;
Rene Andrade
2
, BS ;
Christopher J Miller
2
, MPH ;
Karen R Stolar
3
, MS ;
Muhammad Hasan Arain
1
, MBBS ;
Laila Noor
1
, MBBS ;
Amulya Balagani
1
, MD ;
Akash Jain
1
, MD ;
David Blanco
1
, RPFT ;
Abel Ortiz
1
, CRT ;
Michael S Taylor
4
, BS ;
Alex Stenzler
4
, MD ;
Rohtesh Mehta
3
, MD ;
Uday R Popat
3
, MD ;
Chitra Hosing
3
, MD ;
David E Ost
1
, MD, MPH ;
Richard E Champlin
3
, MD ;
Burton F Dickey
1
, MD ;
Susan K Peterson
2
, PhD
1
Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States
2
Department of Behavioral Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, United States
3
Department of Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX, United States
4
Monitored Therapeutics, Inc, Dublin, OH, United States
*these authors contributed equally
Corresponding Author:
-
Ajay Sheshadri, MSc, MD
-
Department of Pulmonary Medicine
-
The University of Texas MD Anderson Cancer Center
-
1400 Pressler Unit 1462
-
Houston, TX, 77030
-
United States
-
Phone:
1 7135631987
-
Email: asheshadri@mdanderson.org